1 |
Tomeva E, Krammer UDB, Switzeny OJ, Haslberger AG, Hippe B. Sex-Specific miRNA Differences in Liquid Biopsies from Subjects with Solid Tumors and Healthy Controls. Epigenomes 2023;7:2. [PMID: 36648863 DOI: 10.3390/epigenomes7010002] [Reference Citation Analysis]
|
2 |
He X, Ma R, Li Y, Wang H, Yan Y, Mao Y, Liao S, Sun X, Guo S, Guo H, Katsuya T. Association of H-Type Hypertension with miR-21, miR-29, and miR-199 in Kazahks of Xinjiang, China. International Journal of Hypertension 2022;2022:1-10. [DOI: 10.1155/2022/4632087] [Reference Citation Analysis]
|
3 |
Ding J, Wen Y, Yuan X, He X. MicroRNA-mediated reprogramming of glucose, fatty acid and amino acid metabolism in cancer. GENOME INSTAB DIS 2022. [DOI: 10.1007/s42764-022-00078-x] [Reference Citation Analysis]
|
4 |
Wang C, Shen Y, Ni J, Hu W, Yang Y. Effect of chronic stress on tumorigenesis and development. Cell Mol Life Sci 2022;79:485. [PMID: 35974132 DOI: 10.1007/s00018-022-04455-3] [Reference Citation Analysis]
|
5 |
Li Z, Zhang W, Bai J, Li J, Li H. Emerging Role of Helicobacter pylori in the Immune Evasion Mechanism of Gastric Cancer: An Insight Into Tumor Microenvironment-Pathogen Interaction. Front Oncol 2022;12:862462. [DOI: 10.3389/fonc.2022.862462] [Reference Citation Analysis]
|
6 |
Chen Q, Du X, Hu S, Huang Q. NF-κB-Related Metabolic Gene Signature Predicts the Prognosis and Immunotherapy Response in Gastric Cancer. Biomed Res Int 2022;2022:5092505. [PMID: 35036435 DOI: 10.1155/2022/5092505] [Reference Citation Analysis]
|
7 |
Otmani K, Lewalle P. Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications. Front Oncol 2021;11:708765. [PMID: 34722255 DOI: 10.3389/fonc.2021.708765] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
|
8 |
Miao YD, Mu LJ, Mi DH. Metabolism-associated genes in occurrence and development of gastrointestinal cancer: Latest progress and future prospect. World J Gastrointest Oncol 2021; 13(8): 758-771 [PMID: 34457185 DOI: 10.4251/wjgo.v13.i8.758] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
9 |
Rinaldi F, Marchesi F, Palombi F, Pelosi A, Di Pace AL, Sacconi A, Terrenato I, Annibali O, Tomarchio V, Marino M, Cantonetti M, Vaccarini S, Papa E, Moretta L, Bertoni F, Mengarelli A, Regazzo G, Rizzo MG. MiR-22, a serum predictor of poor outcome and therapy response in diffuse large B-cell lymphoma patients. Br J Haematol 2021. [PMID: 34318932 DOI: 10.1111/bjh.17734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
10 |
Mosca L, Vitiello F, Borzacchiello L, Coppola A, Tranchese RV, Pagano M, Caraglia M, Cacciapuoti G, Porcelli M. Mutual Correlation between Non-Coding RNA and S-Adenosylmethionine in Human Cancer: Roles and Therapeutic Opportunities. Cancers (Basel) 2021;13:3264. [PMID: 34209866 DOI: 10.3390/cancers13133264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
11 |
Cuthbertson CR, Arabzada Z, Bankhead A 3rd, Kyani A, Neamati N. A Review of Small-Molecule Inhibitors of One-Carbon Enzymes: SHMT2 and MTHFD2 in the Spotlight. ACS Pharmacol Transl Sci 2021;4:624-46. [PMID: 33860190 DOI: 10.1021/acsptsci.0c00223] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|